Home » Authors » Don Long

Articles by Don Long

Nuance Communications to buy Dictaphone for $357M in cash

Feb. 9, 2006

Commentary: Patchwork of proposals can't produce healthcare 'reform'

Feb. 6, 2006

Financings roundup: Cardica is first device firm to test the 2006 IPO waters

Feb. 6, 2006

CryoCor's atrial flutter PMA said 'not approvable' by FDA

Feb. 6, 2006

Mako in licensing accord with U. of Florida for Material X

Feb. 3, 2006

Schultz: postmarketing focus predates problems of Guidant

Feb. 2, 2006

$745M Angiotech buy of AMI is 'last piece of the puzzle'

Feb. 2, 2006

Mechanical valve to be put to lower drug regimen test

Feb. 1, 2006

CUSTOM II launch grows Xtent focus on multiple stenting

Feb. 1, 2006

Study backs 'preemptive strike' by HALO³⁶⁰ to battle Barrett's

Jan. 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...